217 related articles for article (PubMed ID: 12617874)
1. Role of pharmacogenomics and pharmacodynamics in the treatment of acute lymphoblastic leukaemia.
Pui CH; Relling MV; Evans WE
Best Pract Res Clin Haematol; 2002 Dec; 15(4):741-56. PubMed ID: 12617874
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics of childhood acute lymphoblastic leukemia.
Brenner TL; Pui CH; Evan WE
Curr Opin Mol Ther; 2001 Dec; 3(6):567-78. PubMed ID: 11804271
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics: translating functional genomics into rational therapeutics.
Evans WE; Relling MV
Science; 1999 Oct; 286(5439):487-91. PubMed ID: 10521338
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics influence treatment efficacy in childhood acute lymphoblastic leukemia.
Davidsen ML; Dalhoff K; Schmiegelow K
J Pediatr Hematol Oncol; 2008 Nov; 30(11):831-49. PubMed ID: 18989161
[TBL] [Abstract][Full Text] [Related]
5. Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy.
Cheok MH; Evans WE
Nat Rev Cancer; 2006 Feb; 6(2):117-29. PubMed ID: 16491071
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics of acute leukemia.
Ansari M; Krajinovic M
Pharmacogenomics; 2007 Jul; 8(7):817-34. PubMed ID: 18240908
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of acute lymphoblastic leukemia treatment response.
Cunningham L; Aplenc R
Expert Opin Pharmacother; 2007 Oct; 8(15):2519-31. PubMed ID: 17931087
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics in pediatric leukemia.
Paugh SW; Stocco G; Evans WE
Curr Opin Pediatr; 2010 Dec; 22(6):703-10. PubMed ID: 20861736
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy.
Bosch TM
Methods Mol Biol; 2008; 448():63-76. PubMed ID: 18370231
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in drug-metabolizing enzymes and drug targets.
Hiratsuka M; Mizugaki M
Mol Genet Metab; 2001 Aug; 73(4):298-305. PubMed ID: 11509011
[No Abstract] [Full Text] [Related]
11. The influence of polymorphisms in the drug transporter, ABCB1 on the toxicity of glucocorticoids in Saudi children with acute lymphoblastic leukaemia.
ElFayoumi RI; Hagras MM; Abozenadaha A; Gari M; Abosoudah I; Shinawi T; Mirza T; Bawazir W
Pharmacol Rep; 2019 Feb; 71(1):90-95. PubMed ID: 30508724
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics of acute lymphoblastic leukemia.
Kager L; Evans WE
Curr Opin Hematol; 2006 Jul; 13(4):260-5. PubMed ID: 16755223
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics in acute lymphoblastic leukemia.
Cheok MH; Pottier N; Kager L; Evans WE
Semin Hematol; 2009 Jan; 46(1):39-51. PubMed ID: 19100367
[TBL] [Abstract][Full Text] [Related]
14. Thiopurine S-methyltransferase pharmacogenetics in childhood acute lymphoblastic leukemia.
Yang JJ; Bhojwani D
Methods Mol Biol; 2013; 999():273-84. PubMed ID: 23666706
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomics of acute lymphoid leukemia: new insights into treatment toxicity and efficacy.
Relling MV; Ramsey LB
Hematology Am Soc Hematol Educ Program; 2013; 2013():126-30. PubMed ID: 24319173
[TBL] [Abstract][Full Text] [Related]
16. Associations of novel genetic variations in the folate-related and ARID5B genes with the pharmacokinetics and toxicity of high-dose methotrexate in paediatric acute lymphoblastic leukaemia.
Csordas K; Lautner-Csorba O; Semsei AF; Harnos A; Hegyi M; Erdelyi DJ; Eipel OT; Szalai C; Kovacs GT
Br J Haematol; 2014 Aug; 166(3):410-20. PubMed ID: 24712521
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacogenomics of acute lymphoblastic leukemia].
Ansari M; St-Onge G; Krajinovic M
Med Sci (Paris); 2007 Nov; 23(11):961-7. PubMed ID: 18021708
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetic considerations for acute lymphoblastic leukemia therapies.
Dulucq S; Laverdière C; Sinnett D; Krajinovic M
Expert Opin Drug Metab Toxicol; 2014 May; 10(5):699-719. PubMed ID: 24673379
[TBL] [Abstract][Full Text] [Related]
19. Clinical trials in pharmacogenetics and pharmacogenomics: methods and applications.
Rioux PP
Am J Health Syst Pharm; 2000 May; 57(9):887-98; quiz 899-901. PubMed ID: 10840530
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomic approaches for tailored anti-leukemic therapy in children.
Stocco G; Franca R; Verzegnassi F; Londero M; Rabusin M; Decorti G
Curr Med Chem; 2013; 20(17):2237-53. PubMed ID: 23458619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
